Since FDA approval of transoral robotic surgery (TORS), the publication of TORS related complications has not equaled reports of oncological outcomes. It is important to know the incidence and severity of complications associated with TORS when counseling patients regarding modality of treatment especially when nonsurgical treatment options are available. The introduction of the da Vinci robot (Intuitive Surgical Inc, Sunnyvale, CA, USA) was initially developed in urology and cardiac surgical specialties.
http://ift.tt/2lapUom
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου